Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The RLJ Companies is a diversified holding company founded by Robert L. Johnson, the founder of Black Entertainment Television (BET). The firm manages a wide-ranging portfolio of businesses across several industries, including real estate, private equity, and healthcare. In the life sciences sector, RLJ Companies is most notable for its ownership of RLS (RadioIsotope Life Sciences), which was established through the acquisition of GE Healthcare's U.S. radiopharmacy network. RLS is the largest pure-play radiopharmaceutical company in the United States, maintaining a nationwide network of pharmacies that manufacture and distribute molecular imaging agents and targeted radiotherapies. These products are vital for the diagnosis and treatment of cancer, cardiovascular diseases, and neurological disorders. Through its strategic investments, RLJ Companies continues to expand its influence in the healthcare market, focusing on specialized medical services and advanced diagnostic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RLJ Companies.